| Structure | Chemical Name | CAS | MF |
|
(PC-MAC48) 1 KIT MINI PROTEIN A
|
|
|
|
|
5% Pd/ CaCO3
|
|
|
|
p-Butoxybenzyl chloride
|
|
C11H15ClO
|
|
p-Butoxy-N-[3-(diethylamino)propyl]thiobenzamide
|
16575-27-2
|
C18H30N2OS
|
|
3-(p-Butoxyphenyl)acrylic acid p-nitrophenyl ester
|
|
C19H19NO5
|
|
p-Butoxy-N-[2-(diethylamino)ethyl]thiobenzamide
|
16531-31-0
|
C17H28N2OS
|
|
2-(p-Butoxyphenyl)butyrohydroxamic acid
|
15560-24-4
|
C14H21NO3
|
|
2-(p-Butoxyphenyloxy)-2'-chloro-N-[2-(diethylamino)ethyl]acetanilide
|
27468-70-8
|
C24H33ClN2O3
|
|
3-(p-Butoxyphenyl)acrylohydrazide
|
|
C13H18N2O2
|
|
p-Butoxy-N-(2-piperidinoethyl)benzothioamide
|
72004-15-0
|
|
|
4-[3-(p-Butoxyphenyl)thioureido]-1-naphthalenesulfonic acid sodium salt
|
|
C21H21N2NaO4S2
|
|
3-(p-Butoxyphenyl)-2-propenehydroxamic acid
|
26227-46-3
|
C13H17NO3
|
|
p-Butoxyphenylacetonitrile
|
|
C12H15NO
|
|
2-(p-Butoxyphenyloxy)-2'-chloro-N-[2-(1-pyrrolidinyl)ethyl]acetanilide
|
27585-38-2
|
C24H31ClN2O3
|
|
4-(p-Butoxyphenylthioacetyl)morpholine
|
|
C16H23NO2S
|
|
2-(p-Butoxyphenyl)-4-chloro-6-methyl-5-pyrimidineacetic acid ethyl ester
|
|
C19H23ClN2O3
|
|
p-Butoxycarbanilic acid trans-2-(diethylamino)cyclohexyl ester hydroch loride
|
38198-44-6
|
C21H35ClN2O3
|
|
P-BUTOXYBENZYLAMINE HYDROCHLORIDE
|
59528-29-9
|
C11H18ClNO
|
|
P-BUTOXYBENZYLIDENE-P-OCTYLANILINE
|
39777-26-9
|
C25H35NO
|
|
P-BUTOXYBENZYLIDENE P-HEPTYLANILINE
|
39777-19-0
|
C24H33NO
|
|
P-BUTOXYBENZYLIDENE P-ETHYLANILINE
|
29743-15-5
|
C19H23NO
|
|
P-BUTOXYBENZYLIDENE P-BUTYLANILINE
|
29743-09-7
|
C21H27NO
|
|
P-BUTOXYBENZYLIDENE P-PROPYLANILINE
|
37599-83-0
|
C20H25NO
|
|
P-BUTOXYBENZYLIDENE P-HEXYLANILINE
|
|
C23H31NO
|
|
Bufexamac
|
2438-72-4
|
C12H17NO3
|
|
P-BUTOXYTOLUENE
|
10519-06-9
|
C11H16O
|
|
p-butoxybenzylidenep-hexylaniline
|
39777-12-3
|
C23H31NO
|
|
P-BUTOXYBENZYLIDENE P-CYANOANILINE
|
|
C18H18N2O
|
|
2-(P-BUTOXYANILINO)-N,N-DIMETHYLACETAMIDE
|
|
C14H22N2O2
|
|
P-(BUTOXYCARBONYLOXY)BENZOICACID
|
|
C12H14O5
|
|
P-BUTOXYISOPROPYLBENZENE
|
|
C13H20O
|
|
p-Butoxy-N-(2-diethylaminoethyl)benzenesulfonamide
|
32411-01-1
|
C16H28N2O3S
|
|
p-Butoxybenzoic acid p-cyanophenyl ester
|
54887-92-2
|
C18H17NO3
|
|
3-[3-(p-Butoxyphenyl)thioureido]-1,5-naphthalenedisulfonic acid disodium salt
|
|
C21H20N2Na2O7S3
|
|
p-Butoxy-N-(2-dimethylaminoethyl)benzothioamide
|
69353-41-9
|
|
|
2-(p-Butoxyphenyl)valerohydroxamic acid
|
15560-25-5
|
C15H23NO3
|
|
3-(p-Butoxybenzyl)carbazic acid ethyl ester
|
69353-12-4
|
|
|
2-(p-Butoxyphenoxy)-N-[3-(diethylamino)propyl]-p-methoxyacetanilide
|
27468-61-7
|
C26H38N2O4
|
|
p-Butoxy-N-[3-(1-pyrrolidinyl)propyl]thiobenzamide
|
32412-32-1
|
C18H28N2OS
|
|
7-[3-(p-Butoxyphenyl)thioureido]-1,3-naphthalenedisulfonic acid dipotassium salt
|
|
C21H20K2N2O7S3
|
|
2-[[[(p-Butoxyphenyl)amino]carbonyl]oxy]-N,N,N-triethylethanaminium
|
|
C19H33N2O3+
|
|
p-Butoxy-N-(2-morpholinoethyl)benzothioamide
|
69353-42-0
|
|
|
2-(p-Butoxybenzyl)-4-hydroxy-6-methyl-5-pyrimidineacetic acid ethyl ester
|
|
C20H26N2O4
|
|
p-Butoxycarbanilic acid 2-diethylaminoethyl ester
|
|
C17H28N2O3
|
|
p-Butoxy-N-(3-morpholinopropyl)thiobenzamide
|
32412-30-9
|
C18H28N2O2S
|
|
4-(p-Butoxybenzylidene)-2-phenyl-4,5-dihydrooxazol-5-one
|
|
C20H19NO3
|
|
p-Butoxy-N-(3-piperidinopropyl)thiobenzamide
|
32412-28-5
|
C19H30N2OS
|
|
p-Butoxy-N-[3-(dimethylamino)propyl]thiobenzamide
|
16531-42-3
|
C16H26N2OS
|
|
|
(PC-MAG04) 1 KIT MINI PROTEIN A & G STARTER PACK
|
|
|
|
|
(PC-MA02) 1 KIT MINI PROTEIN A MINI SAMPLE KIT
|
|
|
|
p-Butyl Ibuprofen-d3
|
1346601-56-6
|
C13H18O2
|
|
2-[p-(Butylamino)phenyl]acetic acid
|
|
C12H17NO2
|
|
5-(p-Butyloxyphenyl)-5-methylhydantoin
|
|
C14H18N2O3
|
|
3-(p-Butyrylphenoxy)-1,2-propanediol
|
63834-66-2
|
C13H18O4
|
|
2-[[p-[Butyl(2-cyanoethyl)amino]phenyl]azo]-6-methoxy-3-methylbenzothiazol-3-ium
|
|
C22H26N5OS+
|
|
1-(p-Butylphenoxy)-3-chloro-2-propanol
|
|
C13H19ClO2
|
|
|
α-[p-(Butylthio)phenyl]-1H-imidazole-1-ethanol
|
|
|
|
p-Butylbenzoic acid p-methoxyphenyl ester
|
35684-23-2
|
C18H20O3
|
|
p-(Butylamino)phenyl selenocyanate
|
22037-10-1
|
|
|
P-BUTYLOXYANILINE HYDROCHLORIDE
|
6927-73-7
|
C10H16ClNO
|
|
P-BUTYRYLOXYBEXZALDEHYDE
|
|
C11H12O3
|
|
p-Butyrotoluidide, 2-mercapto- (8CI)
|
802556-86-1
|
C11H15NOS
|
|
P-BUTYL-N-(P-ETHOXYBENZYLIDENE)ANILINE
|
|
C19H23NO
|
|
P-BUTYLPHENOXYACETICACID
|
|
C12H16O3
|
|
P-BUTYRYLOXYBENZALDEHYDE
|
50262-49-2
|
C11H12O3
|
|
p-butylphenylarsonic acid
|
|
C10H15AsO3
|
|
|
p-butylcyclohexyl acetate
|
|
C12H22O2
|
|
p-(butylamino)benzoic acid-2-(diethylamino)ethyl ester
|
12738-75-9
|
|
|
p-[butyl(2-chloroethyl)amino]benzaldehyde
|
4157-74-8
|
C13H18ClNO
|
|
4-Butylphenol
|
1638-22-8
|
C10H14O
|
|
|
PdcA protein
|
|
|
|
|
(Pd(AuPPh3)6(HgNO3))(NO3)
|
|
|
|
|
PCL MAMMALIAN EXPRESSION VECTOR
|
|
|
|
|
PD/C CATALYST
|
|
|
|
|
PDCB Para Di Chloro Benzene
|
|
|
|
|
PDCB/P-Dichlorobenzene
|
|
|
|
|
PCL-NEO MAMMALIAN EXPRESSION VECTOR
|
|
|
|
|
Pcmc-ParaChloroMetaXylenol
|
|
|
|
|
pDCCP1 protein
|
|
|
|
|
PbuX protein, Bacillus subtilis
|
|
|
|
|
PDCD2 protein
|
|
|
|
|
p53, Clone: DO-12, Mab anti-Human, WB
|
|
|
|
|
p53, Clone: DO-1, Mab anti-Human
|
|
|
|
|
P53,CLONE:B449,MABANTI-HUMAN:FROZEN/PARAFFIN,IH/FLOW
|
|
|
|
|
P53,CLONE:DO-14,MABANTI-HUMAN:FROZEN/PARAFFIN
|
|
|
|
|
p53, Clone: BP53-124, Mab anti-Human, frozen/paraffin/cells
|
|
|
|
|
P53,CLONE:BP53-12,MABANTI-HUMAN:PARAFFIN,IH
|
|
|
|
|
p53, Clone: B449, Mab anti-Human
|
|
|
|
|
p53, Clone: BP53-12, Mab anti-
|
|
|
|
|
[p-ClPhe4]cyclic DPDPE
|
|
|
|
|
(PC-MGC48) 1 KIT MINI PROTEIN G
|
|
|
|
|
Pcl:Poly(-Caprolactone)
|
|
|
|
|
PCMF protocol
|
|
|
|
|
PCLP protein
|
|
|
|
|
pCMF1 protein
|
|
|
|
|
(PC-MG02) 1 KIT MINI PROTEIN G MINI SAMPLE KIT
|
|
|
|
|
PD-Chromeon 470
|
|
|
|
|
PD-Chromeon 545, streptavidin
|
|
|
|
|
PD-Chromeon 545, carboxylated
|
|
|
|
|
PD-Chromeon 642, streptavidin
|
|
|